GABA Levels in the Brains of Blind People
GABA Levels in the Occipital Cortex of Blind Human Subjects
2 other identifiers
observational
39
1 country
1
Brief Summary
In blind individuals, the occipital cortex becomes capable of processing tactile and auditory information, a phenomenon described as crossmodal plasticity. GABA is the major inhibitory neurotransmitter in the brain and a possible candidate to mediate this form of human plasticity. We intend to use magnetic resonance spectroscopy (MRS) to measure GABA and hypothesize that GABA levels in the occipital cortex of blind humans will be lower than in sighted controls. Such decrease could possibly mediate compensatory changes in the occipital cortex of the blind. Objective Early blind subjects exhibit better tactile acuity than late blinds or sighted individuals. The purpose of the study is the determine GABA levels in the human occipital cortex after long-term light deprivation (blindness). Study Population Our experiments will make use of early blind, late blind, and sighted control subjects. Design Subject will be identified and will receive clinical and neurological examinations at the NIH. MRS studies will be performed at NIH MRI Center with 3Tesla Magnet. Each subject head will be positioned in an adjustable holder (designed for minimal motion and maximal comfort) such that a flat coil lay just below the occipital cortex. The sequence has been described before \[33\]. The individuals who perform the data analysis will be blind to the purpose of the experiments. Outcome measures The concentration of GABA from the 14 ml voxel over the visual cortex will be measured. Edited proton spectrum of GABA will be compared with the edited sub spectrum of creatine for a concentration reference.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2002
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 11, 2002
CompletedFirst Submitted
Initial submission to the registry
July 26, 2006
CompletedFirst Posted
Study publicly available on registry
July 27, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2008
CompletedJuly 2, 2017
March 3, 2008
July 26, 2006
June 30, 2017
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- All subjects must be between 18 and 55 years of age.
- Healthy sighted volunteers. Legally blind subjects with blindness secondary to retinal lesions or eye removal acquired at ages earlier than 4 years old (EARLY) and after 13 years of age (LATE). The rationale for the distinction is based in our previous studies that indicate different magnitude of brain plasticity depending on the age of acquisition of blindness.
You may not qualify if:
- Pregnant women tested after urine pregnancy test.
- Subjects with metal in the cranium except mouth.
- Subjects with metal fragments from occupational exposure or surgical clips in or near the brain.
- Subjects with blood vessel, cochlear or eye implants.
- Subjects with increased intracranial pressure as evaluated by clinical means.
- Subjects with cardiac or neural pacemakers.
- Subjects with intracardiac lines and implanted medication pumps.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (1)
Micheva KD, Beaulieu C. Neonatal sensory deprivation induces selective changes in the quantitative distribution of GABA-immunoreactive neurons in the rat barrel field cortex. J Comp Neurol. 1995 Oct 30;361(4):574-84. doi: 10.1002/cne.903610403.
PMID: 8576415BACKGROUND
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
July 26, 2006
First Posted
July 27, 2006
Study Start
February 11, 2002
Study Completion
March 3, 2008
Last Updated
July 2, 2017
Record last verified: 2008-03-03